Your browser doesn't support javascript.
loading
Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer.
Lv, Shidong; Wu, Zeyu; Luo, Mayao; Zhang, Yifan; Zhang, Jianqiang; Pascal, Laura E; Wang, Zhou; Wei, Qiang.
Afiliação
  • Lv S; Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China.
  • Wu Z; Department of Urology, University of Pittsburgh School of Medicine-Pittsburgh, Pittsburgh, PA, USA.
  • Luo M; Department of Urology, University of Pittsburgh School of Medicine-Pittsburgh, Pittsburgh, PA, USA.
  • Zhang Y; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University-Changsha, Changsha, China.
  • Zhang J; Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China.
  • Pascal LE; Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China.
  • Wang Z; Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China.
  • Wei Q; Department of urology surgery department ward III, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine-Nanning, Guangxi, China.
Cell Death Dis ; 13(9): 754, 2022 09 01.
Article em En | MEDLINE | ID: mdl-36050295
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ivermectina / Fator 3-alfa Nuclear de Hepatócito / Autoantígeno Ku Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ivermectina / Fator 3-alfa Nuclear de Hepatócito / Autoantígeno Ku Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido